Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer

Case Report: Probable Cerebral Amyloid Angiopathy-Related Inflammation During Bevacizumab Treatment for Metastatic Cervical Cancer

Bevacizumab is an anti-angiogenic monoclonal antibody targeting Vascular Endothelial Growth Factor (VEGF) that induces the proliferation and migration of vascular endothelial cells thus, promoting vasculogenesis. Bevacizumab inhibits cancer angiogenesis, which is fundamental for either tumor develop...

Full description

Bibliographic Details
Main Authors: Tatiana Koudriavtseva, Svetlana Lorenzano, Vincenzo Anelli, Domenico Sergi, Annunziata Stefanile, Enea Gino Di Domenico, Marta Maschio, Edvina Galiè, Carlo Piantadosi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-07-01
Series:Frontiers in Oncology
Subjects:
case report
bevacizumab
metastatic cervical cancer
cerebral amyloid angiopathy-related inflammation
microhemorrhages 3
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2021.669753/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2021.669753/full

Similar Items